Medtronic has been making significant strides in its Cranial & Spinal Technologies (CST) business unit recently.
FDA clearance for Stealth AXiS™, PMA approval for Infuse™ TLIF, and a strong Q3 earnings beat set the stage for what ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results